{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:51:55Z","timestamp":1785883915881,"version":"3.56.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T00:00:00Z","timestamp":1437436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T00:00:00Z","timestamp":1437436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00134-015-3978-8","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T10:48:20Z","timestamp":1437389300000},"page":"1739-1751","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting"],"prefix":"10.1007","volume":"41","author":[{"given":"Werner C.","family":"Albrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Harbarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,21]]},"reference":[{"key":"3978_CR1","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1001\/jama.2009.1754","volume":"302","author":"JL Vincent","year":"2009","unstructured":"Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323\u20132329","journal-title":"JAMA"},{"key":"3978_CR2","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1086\/420741","volume":"38","author":"JE Fischer","year":"2004","unstructured":"Fischer JE, Harbarth S, Agthe AG, Benn A, Ringer SA, Goldmann DA, Fanconi S (2004) Quantifying uncertainty: physicians\u2019 estimates of infection in critically ill neonates and children. Clin Infect Dis 38:1383\u20131390","journal-title":"Clin Infect Dis"},{"key":"3978_CR3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/CCM.0b013e3181cc4824","volume":"38","author":"DF Gaieski","year":"2010","unstructured":"Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, Furia FF, Shofer FS, Goyal M (2010) Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38:1045\u20131053","journal-title":"Crit Care Med"},{"key":"3978_CR4","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589\u20131596","journal-title":"Crit Care Med"},{"key":"3978_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","volume":"39","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165\u2013228","journal-title":"Intensive Care Med"},{"key":"3978_CR6","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1086\/374243","volume":"36","author":"DL Paterson","year":"2003","unstructured":"Paterson DL, Rice LB (2003) Empirical antibiotic choice for the seriously ill patient: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive? Clin Infect Dis 36:1006\u20131012","journal-title":"Clin Infect Dis"},{"key":"3978_CR7","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1164\/ajrccm.163.6.2007020","volume":"163","author":"PJW Dennesen","year":"2001","unstructured":"Dennesen PJW, van der Ven AJAM, Kessels AGH, Ramsay G, Bonten MJM (2001) Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 163:1371\u20131375","journal-title":"Am J Respir Crit Care Med"},{"key":"3978_CR8","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/jac\/dkh416","volume":"54","author":"A Corona","year":"2004","unstructured":"Corona A, Wilson AP, Grassi M, Singer M (2004) Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapy. J Antimicrob Chemother 54:809\u2013817","journal-title":"J Antimicrob Chemother"},{"key":"3978_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/cc6860","volume":"12","author":"Y Shehabi","year":"2008","unstructured":"Shehabi Y, Seppelt I (2008) Pro\/Con debate: is procalcitonin useful for guiding antibiotic decision making in critically ill patients? Crit Care 12:211","journal-title":"Crit Care"},{"key":"3978_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/cc8155","volume":"14","author":"M Christ-Crain","year":"2010","unstructured":"Christ-Crain M, Opal SM (2010) Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care 14:203","journal-title":"Crit Care"},{"key":"3978_CR11","doi-asserted-by":"publisher","first-page":"R38","DOI":"10.1186\/cc5723","volume":"11","author":"K Kofoed","year":"2007","unstructured":"Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J, Larsen K (2007) Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 11:R38","journal-title":"Crit Care"},{"key":"3978_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1164\/ajrccm.164.3.2009052","volume":"164","author":"S Harbarth","year":"2001","unstructured":"Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J (2001) Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164:396\u2013402","journal-title":"Am J Respir Crit Care Med"},{"key":"3978_CR13","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/00003246-200004000-00011","volume":"28","author":"B Muller","year":"2000","unstructured":"Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R (2000) Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28:977\u2013983","journal-title":"Crit Care Med"},{"key":"3978_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1086\/421997","volume":"39","author":"L Simon","year":"2004","unstructured":"Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206\u2013217","journal-title":"Clin Infect Dis"},{"key":"3978_CR15","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s00134-009-1746-3","volume":"36","author":"PR Ingram","year":"2010","unstructured":"Ingram PR, Inglis T, Moxon D, Speers D (2010) Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. Intensive Care Med 36:528\u2013532","journal-title":"Intensive Care Med"},{"key":"3978_CR16","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s00134-011-2189-1","volume":"37","author":"E Cuquemelle","year":"2011","unstructured":"Cuquemelle E, Soulis F, Villers D, Roche-Campo F, Ara Somohano C, Fartoukh M, Kouatchet A, Mourvillier B, Dellamonica J, Picard W, Schmidt M, Boulain T, Brun-Buisson C (2011) Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Med 37:796\u2013800","journal-title":"Intensive Care Med"},{"key":"3978_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1128\/CMR.00016-12","volume":"25","author":"K Reinhart","year":"2012","unstructured":"Reinhart K, Bauer M, Riedemann NC, Hartog CS (2012) New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev 25:609\u2013634","journal-title":"Clin Microbiol Rev"},{"key":"3978_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1476-5381.2009.00433.x","volume":"159","author":"KL Becker","year":"2010","unstructured":"Becker KL, Snider R, Nylen ES (2010) Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol 159:253\u2013264","journal-title":"Br J Pharmacol"},{"key":"3978_CR19","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s001340000624","volume":"26","author":"K Reinhart","year":"2000","unstructured":"Reinhart K, Karzai W, Meisner M (2000) Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 26:1193\u20131200","journal-title":"Intensive Care Med"},{"key":"3978_CR20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s15010-007-7065-0","volume":"35","author":"P Schuetz","year":"2007","unstructured":"Schuetz P, Mueller B, Trampuz A (2007) Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection 35:352\u2013355","journal-title":"Infection"},{"key":"3978_CR21","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1172\/JCI116336","volume":"91","author":"DM Vigushin","year":"1993","unstructured":"Vigushin DM, Pepys MB, Hawkins PN (1993) Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 91:1351\u20131357","journal-title":"J Clin Invest"},{"key":"3978_CR22","first-page":"451","volume":"135","author":"M Christ-Crain","year":"2005","unstructured":"Christ-Crain M, Muller B (2005) Procalcitonin in bacterial infections\u2013hype, hope, more or less? Swiss Med Wkly 135:451\u2013460","journal-title":"Swiss Med Wkly"},{"key":"3978_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1471-2253-14-102","volume":"14","author":"A Kutz","year":"2014","unstructured":"Kutz A, Grolimund E, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Zimmerli W, Mueller B, Schuetz P (2014) Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients. BMC Anesthesiol 14:102","journal-title":"BMC Anesthesiol"},{"key":"3978_CR24","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/cid\/ciu732","volume":"59","author":"E Grace","year":"2014","unstructured":"Grace E, Turner RM (2014) Use of procalcitonin in patients with various degrees of chronic kidney disease including renal replacement therapy. Clin Infect Dis 59:1761\u20131767","journal-title":"Clin Infect Dis"},{"key":"3978_CR25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Regnier B, Brun-Buisson C, Chastre J, Wolff M (2010) Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375:463\u2013474","journal-title":"Lancet"},{"key":"3978_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3109\/00365548.2011.554855","volume":"43","author":"I Koivula","year":"2011","unstructured":"Koivula I, Hamalainen S, Jantunen E, Pulkki K, Kuittinen T, Nousiainen T, Juutilainen A (2011) Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia. Scand J Infect Dis 43:471\u2013478","journal-title":"Scand J Infect Dis"},{"key":"3978_CR27","doi-asserted-by":"publisher","first-page":"R129","DOI":"10.1186\/cc10242","volume":"15","author":"P Povoa","year":"2011","unstructured":"Povoa P, Souza-Dantas VC, Soares M, Salluh JF (2011) C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia. Crit Care 15:R129","journal-title":"Crit Care"},{"key":"3978_CR28","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/cc8872","volume":"14","author":"C Pierrakos","year":"2010","unstructured":"Pierrakos C, Vincent JL (2010) Sepsis biomarkers: a review. Crit Care 14:R15","journal-title":"Crit Care"},{"key":"3978_CR29","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1097\/CCM.0b013e3181f17bf9","volume":"38","author":"P Kopterides","year":"2010","unstructured":"Kopterides P, Siempos II, Tsangaris I, Tsantes A, Armaganidis A (2010) Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med 38:2229\u20132241","journal-title":"Crit Care Med"},{"key":"3978_CR30","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1473-3099(12)70323-7","volume":"13","author":"C Wacker","year":"2013","unstructured":"Wacker C, Prkno A, Brunkhorst FM, Schlattmann P (2013) Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 13:426\u2013435","journal-title":"Lancet Infect Dis"},{"key":"3978_CR31","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1473-3099(13)70026-4","volume":"13","author":"A Afshari","year":"2013","unstructured":"Afshari A, Harbarth S (2013) Procalcitonin as diagnostic biomarker of sepsis. Lancet Infect Dis 13:382\u2013384","journal-title":"Lancet Infect Dis"},{"key":"3978_CR32","doi-asserted-by":"publisher","first-page":"R291","DOI":"10.1186\/cc13157","volume":"17","author":"A Prkno","year":"2013","unstructured":"Prkno A, Wacker C, Brunkhorst FM, Schlattmann P (2013) Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock\u2014a systematic review and meta-analysis. Crit Care 17:R291","journal-title":"Crit Care"},{"key":"3978_CR33","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00134-003-1761-8","volume":"29","author":"JE Fischer","year":"2003","unstructured":"Fischer JE, Bachmann LM, Jaeschke R (2003) A readers\u2019 guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med 29:1043\u20131051","journal-title":"Intensive Care Med"},{"key":"3978_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2334-7-10","volume":"7","author":"B Muller","year":"2007","unstructured":"Muller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, Nusbaumer C, Tamm M, Christ-Crain M (2007) Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 7:10","journal-title":"BMC Infect Dis"},{"key":"3978_CR35","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1056\/NEJMoa1415236","volume":"372","author":"KM Kaukonen","year":"2015","unstructured":"Kaukonen KM, Bailey M, Pilcher D, Cooper DJ, Bellomo R (2015) Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 372:1629\u20131638","journal-title":"N Engl J Med"},{"key":"3978_CR36","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1097\/CCM.0b013e31821e8791","volume":"39","author":"JU Jensen","year":"2011","unstructured":"Jensen JU, Hein L, Lundgren B, Bestle MH, Mohr TT, Andersen MH, Thornberg KJ, Loken J, Steensen M, Fox Z, Tousi H, Soe-Jensen P, Lauritsen AO, Strange D, Petersen PL, Reiter N, Hestad S, Thormar K, Fjeldborg P, Larsen KM, Drenck NE, Ostergaard C, Kjaer J, Grarup J, Lundgren JD (2011) Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 39:2048\u20132058","journal-title":"Crit Care Med"},{"key":"3978_CR37","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1097\/CCM.0b013e318251517a","volume":"40","author":"N Layios","year":"2012","unstructured":"Layios N, Lambermont B, Canivet JL, Morimont P, Preiser JC, Garweg C, Ledoux D, Frippiat F, Piret S, Giot JB, Wiesen P, Meuris C, Massion P, Leonard P, Nys M, Lancellotti P, Chapelle JP, Damas P (2012) Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med 40:2304\u20132309","journal-title":"Crit Care Med"},{"key":"3978_CR38","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1164\/rccm.200708-1238OC","volume":"177","author":"V Nobre","year":"2008","unstructured":"Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J (2008) Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 177:498\u2013505","journal-title":"Am J Respir Crit Care Med"},{"key":"3978_CR39","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1164\/rccm.201408-1483OC","volume":"190","author":"Y Shehabi","year":"2014","unstructured":"Shehabi Y, Sterba M, Garrett PM, Rachakonda KS, Stephens D, Harrigan P, Walker A, Bailey MJ, Johnson B, Millis D, Ding G, Peake S, Wong H, Thomas J, Smith K, Forbes L, Hardie M, Micallef S, Fraser JF (2014) Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial. Am J Respir Crit Care Med 190:1102\u20131110","journal-title":"Am J Respir Crit Care Med"},{"key":"3978_CR40","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1183\/09031936.00053209","volume":"34","author":"D Stolz","year":"2009","unstructured":"Stolz D, Smyrnios N, Eggimann P, Pargger H, Thakkar N, Siegemund M, Marsch S, Azzola A, Rakic J, Mueller B, Tamm M (2009) Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J 34:1364\u20131375","journal-title":"Eur Respir J"},{"key":"3978_CR41","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/cc7903","volume":"13","author":"M Hochreiter","year":"2009","unstructured":"Hochreiter M, Kohler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, Schroeder S (2009) Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care 13:R83","journal-title":"Crit Care"},{"key":"3978_CR42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00423-008-0432-1","volume":"394","author":"S Schroeder","year":"2009","unstructured":"Schroeder S, Hochreiter M, Koehler T, Schweiger AM, Bein B, Keck FS, von Spiegel T (2009) Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg 394:221\u2013226","journal-title":"Langenbecks Arch Surg"},{"key":"3978_CR43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/cid\/cir408","volume":"53","author":"R Agarwal","year":"2011","unstructured":"Agarwal R, Schwartz DN (2011) Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review. Clin Infect Dis 53:379\u2013387","journal-title":"Clin Infect Dis"},{"key":"3978_CR44","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","volume":"290","author":"J Chastre","year":"2003","unstructured":"Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S (2003) Comparison of 8 vs 15\u00a0days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290:2588\u20132598","journal-title":"JAMA"},{"key":"3978_CR45","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/cid\/cir063","volume":"52","author":"Y Hayashi","year":"2011","unstructured":"Hayashi Y, Paterson DL (2011) Strategies for reduction in duration of antibiotic use in hospitalized patients. Clin Infect Dis 52:1232\u20131240","journal-title":"Clin Infect Dis"},{"key":"3978_CR46","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/archinternmed.2012.770","volume":"172","author":"WC Albrich","year":"2012","unstructured":"Albrich WC, Dusemund F, Bucher B, Meyer S, Thomann R, K\u00fchn F, Bassetti S, Sprenger M, Baechli E, Sigrist T, Schwietert M, Amin D, Hausfater P, Carre E, Gaillat J, Schuetz P, Regez K, Bossart R, Schild U, Mueller B (2012) Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in \u201creal life\u201d: an international, multicenter post-study survey (ProREAL). Arch Intern Med 172:715\u2013722","journal-title":"Arch Intern Med"},{"key":"3978_CR47","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1001\/jamainternmed.2014.4887","volume":"174","author":"N Garin","year":"2014","unstructured":"Garin N, Genne D, Carballo S, Chuard C, Eich G, Hugli O, Lamy O, Nendaz M, Petignat PA, Perneger T, Rutschmann O, Seravalli L, Harbarth S, Perrier A (2014) Beta-lactam monotherapy vs beta-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. JAMA Intern Med 174:1894\u20131901","journal-title":"JAMA Intern Med"},{"key":"3978_CR48","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","volume":"385","author":"CA Blum","year":"2015","unstructured":"Blum CA, Nigro N, Briel M, Schuetz P, Ullmer E, Suter-Widmer I, Winzeler B, Bingisser R, Elsaesser H, Drozdov D, Arici B, Urwyler SA, Refardt J, Tarr P, Wirz S, Thomann R, Baumgartner C, Duplain H, Burki D, Zimmerli W, Rodondi N, Mueller B, Christ-Crain M (2015) Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 385:1511\u20131518","journal-title":"Lancet"},{"key":"3978_CR49","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1007\/s00134-008-1112-x","volume":"34","author":"CE Luyt","year":"2008","unstructured":"Luyt CE, Combes A, Reynaud C, Hekimian G, Nieszkowska A, Tonnellier M, Aubry A, Trouillet JL, Bernard M, Chastre J (2008) Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 34:1434\u20131440","journal-title":"Intensive Care Med"},{"key":"3978_CR50","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1097\/01.CCM.0000239116.01855.61","volume":"34","author":"JU Jensen","year":"2006","unstructured":"Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M (2006) Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 34:2596\u20132602","journal-title":"Crit Care Med"},{"key":"3978_CR51","doi-asserted-by":"crossref","unstructured":"Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Luyt CE, Chastre J, Tubach F, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Mueller B (2012) Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis 55:651\u2013662","DOI":"10.1093\/cid\/cis464"},{"key":"3978_CR52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/2110-5820-2-32","volume":"2","author":"P Povoa","year":"2012","unstructured":"Povoa P, Salluh JI (2012) Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review. Ann Intensive Care 2:32","journal-title":"Ann Intensive Care"},{"key":"3978_CR53","first-page":"583","volume":"53","author":"P Schuetz","year":"2015","unstructured":"Schuetz P, Balk R, Briel M, Kutz A, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Luyt CE, Chastre J, Tubach F, Mueller B, Lacey MJ, Ohsfeldt RL, Scheibling CM, Schneider JE (2015) Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective. Clin Chem Lab Med 53:583\u2013592","journal-title":"Clin Chem Lab Med"},{"key":"3978_CR54","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1097\/CCM.0b013e31828e969f","volume":"41","author":"CF Oliveira","year":"2013","unstructured":"Oliveira CF, Botoni FA, Oliveira CR, Silva CB, Pereira HA, Serufo JC, Nobre V (2013) Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial. Crit Care Med 41:2336\u20132343","journal-title":"Crit Care Med"},{"key":"3978_CR55","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/cc13870","volume":"18","author":"JI Salluh","year":"2014","unstructured":"Salluh JI, Nobre V, Povoa P (2014) Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers. Crit Care 18:142","journal-title":"Crit Care"},{"key":"3978_CR56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1155\/2013\/141989","volume":"24","author":"TC Havey","year":"2013","unstructured":"Havey TC, Fowler RA, Pinto R, Elligsen M, Daneman N (2013) Duration of antibiotic therapy for critically ill patients with bloodstream infections: a retrospective cohort study. Can J Infect Dis Med Microbiol 24:129\u2013137","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"3978_CR57","doi-asserted-by":"publisher","first-page":"R267","DOI":"10.1186\/cc10545","volume":"15","author":"TC Havey","year":"2011","unstructured":"Havey TC, Fowler RA, Daneman N (2011) Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis. Crit Care 15:R267","journal-title":"Crit Care"},{"key":"3978_CR58","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1056\/NEJMoa1411162","volume":"372","author":"RG Sawyer","year":"2015","unstructured":"Sawyer RG, Claridge JA, Nathens AB, Rotstein OD, Duane TM, Evans HL, Cook CH, O\u2019Neill PJ, Mazuski JE, Askari R, Wilson MA, Napolitano LM, Namias N, Miller PR, Dellinger EP, Watson CM, Coimbra R, Dent DL, Lowry SF, Cocanour CS, West MA, Banton KL, Cheadle WG, Lipsett PA, Guidry CA, Popovsky K (2015) Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 372:1996\u20132005","journal-title":"N Engl J Med"},{"issue":"Suppl 6","key":"3978_CR59","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","volume":"17","author":"M Woodhead","year":"2011","unstructured":"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ (2011) Guidelines for the management of adult lower respiratory tract infections\u2014full version. Clin Microbiol Infect 17(Suppl 6):E1\u201359","journal-title":"Clin Microbiol Infect"},{"key":"3978_CR60","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52:e103\u2013e120","journal-title":"Clin Infect Dis"},{"key":"3978_CR61","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1164\/ajrccm.162.2.9909095","volume":"162","author":"N Singh","year":"2000","unstructured":"Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL (2000) Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 162:505\u2013511","journal-title":"Am J Respir Crit Care Med"},{"key":"3978_CR62","doi-asserted-by":"publisher","first-page":"621","DOI":"10.7326\/0003-4819-132-8-200004180-00004","volume":"132","author":"JY Fagon","year":"2000","unstructured":"Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stephan F, Similowski T, Mercat A, Diehl JL, Sollet JP, Tenaillon A (2000) Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 132:621\u2013630","journal-title":"Ann Intern Med"},{"key":"3978_CR63","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1378\/chest.125.5.1791","volume":"125","author":"ST Micek","year":"2004","unstructured":"Micek ST, Ward S, Fraser VJ, Kollef MH (2004) A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 125:1791\u20131799","journal-title":"Chest"},{"key":"3978_CR64","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s00134-015-3719-z","volume":"41","author":"M Bassetti","year":"2015","unstructured":"Bassetti M, De Waele JJ, Eggimann P, Garnacho-Montero J, Kahlmeter G, Menichetti F, Nicolau DP, Paiva JA, Tumbarello M, Welte T, Wilcox M, Zahar JR, Poulakou G (2015) Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med 41:776\u2013795","journal-title":"Intensive Care Med"},{"key":"3978_CR65","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5492\/wjccm.v4.i1.13","volume":"4","author":"YZ Zhang","year":"2015","unstructured":"Zhang YZ, Singh S (2015) Antibiotic stewardship programmes in intensive care units: why, how, and where are they leading us. World J Crit Care Med 4:13\u201328","journal-title":"World J Crit Care Med"},{"key":"3978_CR66","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/cid\/cit498","volume":"57","author":"AM Huang","year":"2013","unstructured":"Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, Collins CD, Nagel JL (2013) Impact of rapid organism identification via matrix-assisted laser desorption\/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis 57:1237\u20131245","journal-title":"Clin Infect Dis"},{"key":"3978_CR67","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/jac\/dkr137","volume":"66","author":"R Kaki","year":"2011","unstructured":"Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N (2011) Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother 66:1223\u20131230","journal-title":"J Antimicrob Chemother"},{"key":"3978_CR68","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.epidem.2012.12.001","volume":"4","author":"A Hurford","year":"2012","unstructured":"Hurford A, Morris AM, Fisman DN, Wu J (2012) Linking antimicrobial prescribing to antimicrobial resistance in the ICU: before and after an antimicrobial stewardship program. Epidemics 4:203\u2013210","journal-title":"Epidemics"},{"key":"3978_CR69","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00134-013-3077-7","volume":"40","author":"J Garnacho-Montero","year":"2014","unstructured":"Garnacho-Montero J, Gutierrez-Pizarraya A, Escoresca-Ortega A, Corcia-Palomo Y, Fernandez-Delgado E, Herrera-Melero I, Ortiz-Leyba C, Marquez-Vacaro JA (2014) De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 40:32\u201340","journal-title":"Intensive Care Med"},{"key":"3978_CR70","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00134-014-3411-8","volume":"40","author":"M Leone","year":"2014","unstructured":"Leone M, Bechis C, Baumstarck K, Lefrant JY, Albanese J, Jaber S, Lepape A, Constantin JM, Papazian L, Bruder N, Allaouchiche B, Bezulier K, Antonini F, Textoris J, Martin C (2014) De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med 40:1399\u20131408","journal-title":"Intensive Care Med"},{"key":"3978_CR71","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s00134-014-3488-0","volume":"40","author":"JJ De Waele","year":"2014","unstructured":"De Waele JJ, Bassetti M, Martin-Loeches I (2014) Impact of de-escalation on ICU patients\u2019 prognosis. Intensive Care Med 40:1583\u20131585","journal-title":"Intensive Care Med"},{"key":"3978_CR72","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00134-013-3148-9","volume":"40","author":"D Mokart","year":"2014","unstructured":"Mokart D, Slehofer G, Lambert J, Sannini A, Chow-Chine L, Brun JP, Berger P, Duran S, Faucher M, Blache JL, Saillard C, Vey N, Leone M (2014) De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med 40:41\u201349","journal-title":"Intensive Care Med"},{"key":"3978_CR73","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00134-013-3154-y","volume":"40","author":"MH Kollef","year":"2014","unstructured":"Kollef MH (2014) What can be expected from antimicrobial de-escalation in the critically ill? Intensive Care Med 40:92\u201395","journal-title":"Intensive Care Med"},{"key":"3978_CR74","doi-asserted-by":"publisher","first-page":"R225","DOI":"10.1186\/cc9373","volume":"14","author":"J Morel","year":"2010","unstructured":"Morel J, Casoetto J, Jospe R, Aubert G, Terrana R, Dumont A, Molliex S, Auboyer C (2010) De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit. Crit Care 14:R225","journal-title":"Crit Care"},{"key":"3978_CR75","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1007\/s00134-014-3485-3","volume":"40","author":"JF Timsit","year":"2014","unstructured":"Timsit JF, Harbarth S, Carlet J (2014) De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU. Intensive Care Med 40:1580\u20131582","journal-title":"Intensive Care Med"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-015-3978-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-015-3978-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-015-3978-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-015-3978-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:52:17Z","timestamp":1744174337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-015-3978-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,21]]},"references-count":75,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["3978"],"URL":"https:\/\/doi.org\/10.1007\/s00134-015-3978-8","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,21]]},"assertion":[{"value":"29 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"WCA has received support from BRAHMS Thermo Fisher and from bioM\u00e9rieux to attend meetings and fulfilled speaking engagements and served as consultants for BRAHMS Thermo Fisher. SH has received consultant and speaker honoraria from bioM\u00e9rieux, Da Volterra, and Destiny Pharma. In 2007, SH received a research grant from Brahms GmbH, the initial producer of a procalcitonin assay, to do a clinical trial on procalcitonin. He also received a speaker honorarium from this company in 2009. SH has received research funds from Pfizer, B Braun, the Centre de Recherche Clinique at the Geneva University Hospitals, and the European Commission (SATURN, AIDA, R-Gnosis, Rapp-ID, DRIVE-AB, and COMBACTE network contracts).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}